Recently, the hepatoma arterial-embolization prognostic (HAP) score and the modified HAP-II (mHAP-II) score that contain four variables (serum alpha-fetoprotein [AFP], tumor burden, serum albumin, and total serum bilirubin) have also been proposed with significant prognostic performance in selection of optimal candidates for TACE [16, 17]. Here, ALB is linked to hepatocellular carcinoma.